Research & Development

Could a Novel Drug Enhance Muscle Repair in Duchenne Muscular Dystrophy?
Research & Development Could a Novel Drug Enhance Muscle Repair in Duchenne Muscular Dystrophy?

A groundbreaking study led by Natasha Chang at McGill University has shown that a novel drug, K884, holds promise for treating Duchenne muscular dystrophy (DMD), a devastating genetic disorder characterized by severe muscle degeneration. Unlike conventional treatments, which primarily focus on

Breakthrough in S. aureus Vaccine Research Offers New Hope for Immunization
Research & Development Breakthrough in S. aureus Vaccine Research Offers New Hope for Immunization

The recent discovery by researchers at the University of California San Diego (UCSD) has shed light on why previous vaccines against Staphylococcus aureus (S. aureus) have failed in human trials despite success in mouse models. This breakthrough could pave the way for effective vaccines against

Can Genetic Insights Improve Treatment for Cryptococcosis Infections?
Research & Development Can Genetic Insights Improve Treatment for Cryptococcosis Infections?

Cryptococcus neoformans infections often pose a significant threat to individuals with weakened immune systems, such as those with HIV/AIDS or organ transplant recipients. These infections can lead to cryptococcosis, a severe condition that initially affects the lungs and may spread to the brain,

CBD Reduces Overall Anxiety in Advanced Breast Cancer Patients Study Finds
Research & Development CBD Reduces Overall Anxiety in Advanced Breast Cancer Patients Study Finds

The effectiveness of cannabidiol (CBD) in reducing anxiety among patients with advanced breast cancer has become an intriguing subject for researchers, especially in the context of scan-related anxiety. A recent study conducted by researchers from the Dana-Farber Cancer Institute and Mass General

WashU Medicine Receives $10.8M Grant for Groundbreaking Leukemia Research
Research & Development WashU Medicine Receives $10.8M Grant for Groundbreaking Leukemia Research

Washington University School of Medicine in St. Louis (WashU Medicine) has been awarded a significant five-year, $10.8 million grant from the National Cancer Institute (NCI) of the National Institutes of Health (NIH). This funding renewal aims to advance the institution's ongoing research in

New Molecular Insights into Rett Syndrome from MeCP2 Gene Study
Research & Development New Molecular Insights into Rett Syndrome from MeCP2 Gene Study

Rett syndrome is a severe neurological disorder primarily affecting young girls, leading to significant cognitive, motor, and communication impairments. The disorder is linked to mutations in the MeCP2 gene, which encodes the methyl-CpG binding protein 2 (MeCP2). Researchers have long sought to

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later